India develops local bird flu vaccine

NewsGuard 100/100 Score

Officials in India say they have successfully produced a vaccine against bird flu in poultry.

Indian agricultural scientists believe they have made a breakthrough in developing a vaccine against the deadly H5N1 virus and have done so in a relatively short period of time.

Sharad Pawar the country's Agriculture Minister and president of the Indian Council of Agricultural Research says the vaccine was derived from the H5N1 strain of the bird flu virus.

India has invested Rs.80m ($1.8m) in the development of a vaccine following the culling of hundreds of thousands of birds since February when it reported its first outbreak in poultry, resulting in huge losses for many poultry farmers.

No human infections have been reported, but Indian authorities were quick to act and thousands of people were monitored for flu-like symptoms.

The country had been relying on vaccine imported from Netherlands and produced the vaccine at a laboratory in Bhopal which is the main facility in the country for testing and research.

India is not at this stage developing a vaccine for humans.

Indian authorities say bird flu outbreaks have subsided and in six months the country could be declared free from the infection.

According to the World Health Organisation the H5N1 strain of avian flu has to date killed 132 people since 2003.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oxford University and Brazil partner to advance malaria vaccine development